ArticleFrontiers in immunology2022

Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients.

Zarema Albakova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.